Alnylam Pharmaceuticals Crosses Above its 10-day MA (ALNY)
Alnylam Pharmaceuticals (NASDAQ:ALNY) shares have crossed bullishly above their 10-day moving average of $74.15 on a volume of 209K shares. Swing traders may find an opportunity for a long position, as such a crossover often suggests higher prices in the near term.
Over the past year, Alnylam Pharmaceuticals has traded in a range of $49.96 to $140.00 and is now at $74.95, 50% above that low. Over the past week, the 200-day moving average (MA) has gone down 1.7% while the 50-day MA has remained constant.
SmarTrend recommended that subscribers consider buying shares of Alnylam Pharmaceuticals on July 7th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $61.09. Since that recommendation, shares of Alnylam Pharmaceuticals have risen 19.1%. We continue to monitor ALNY for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: moving crosses alnylam pharmaceuticals